Prevalence of Dry Eye Disease in Patients Diagnosed With Rheumatoid Arthritis

NCT02252744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 286

Last updated 2016-02-03

Study results available
· View outcomes & findings →

Summary

This study will evaluate the prevalence of dry eye disease in patients diagnosed with rheumatoid arthritis. No treatment is administered in this study.

Conditions

Interventions

OTHER

No intervention

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY
  • Western University of Health Sciences

    lead OTHER

Principal Investigators

  • Jasmine W Yumori, OD FAAO · Western University of Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-06-30
Completion
2014-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252744 on ClinicalTrials.gov